Latest Production News

HighCom Limited reveals a challenging first half of FY26 with losses linked to the US Government shutdown but signals a confident turnaround in the second half driven by diversification and operational improvements.

Great Dirt Resources has confirmed high-grade manganese mineralisation in NSW and identified 24 new exploration targets through advanced R&D techniques, supported by a $315k tax rebate and a strong cash position.

Power Minerals has terminated its joint venture with Navigate Energy on the Rincon Lithium Project, opting to retain full ownership and seek new partners amid a buoyant lithium market.

Argent BioPharma has signed a binding agreement to acquire AusCann’s 48% stake in CannPal, enhancing its clinical and intellectual property assets for CannEpil®. The deal includes an option for the Neuvis® drug-delivery platform and aligns with Argent’s U.S. dual-listing ambitions.

Southern Cross Gold Consolidated Ltd throws its weight behind Australia’s new A$1.2 billion Critical Minerals Strategic Reserve, spotlighting its Sunday Creek gold-antimony project as a key player in securing domestic supply and reducing reliance on China.

Resolution Minerals reports outstanding high-grade antimony, silver, and gold assay results from rock samples at its Antimony Ridge Mine in Idaho, reinforcing the project's strategic importance in the US critical minerals landscape.

Prospect Resources has confirmed significant gold by-product mineralisation at its Nyungu Central deposit, potentially boosting the economics of the Mumbezhi Copper Project in Zambia. Updated resource estimates incorporating these findings are expected in Q1 2026.

Robex Resources has received final court approval for its merger with Predictive Discovery, setting the stage for completion in early 2026 pending regulatory consents. This move could reshape the future of Robex’s West African gold projects.

Viking Mines reports promising high-grade tungsten oxide assay results from its Linka Tungsten Project in Nevada, reinforcing the project's potential amid soaring global scheelite prices.

Kinatico Limited has reported a robust 42% increase in its SaaS revenue for Q2FY26, driven by strong operational execution and the launch of its new Kinatico Compliance solution.

Proteomics International Laboratories has appointed David Morris as CEO and Managing Director, marking a strategic shift towards commercialising its Promarker® diagnostic technology. Morris brings extensive global healthcare leadership experience to lead the company’s next growth phase.

ECS Botanics reports a $218k positive operating cash flow in Q2 FY26, driven by strong B2C growth and new product launches. The company also secured $1.95 million in funding to fuel European expansion and product development.